Abstract
No public abstract is available from the verified source records.
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureRobert S. Zhang, Pablo Villar Calle, JIWON KIM, Jonathan W. Weinsaft
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
openalex
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases
10.1093/eurheartj/ehv727 · 2016
Dilated cardiomyopathy: the complexity of a diverse genetic architecture
10.1038/nrcardio.2013.105 · 2013
Mutations of TTN, encoding the giant muscle filament titin, cause familial dilated cardiomyopathy
10.1038/ng815 · 2002
Truncations of titin causing dilated cardiomyopathy
10.1056/nejmoa1110186 · 2012
The registry of the international society for heart and lung transplantation: thirty-third adult heart transplantation report-2016; focus theme: primary diagnostic indications for transplant
10.1016/j.healun.2016.08.017 · 2016
Sex- and age-based differences in the natural history and outcome of dilated cardiomyopathy
10.1002/ejhf.1216 · 2018
Multimodality imaging in the diagnosis, risk stratification, and management of patients with dilated cardiomyopathies: an expert consensus document from the European association of cardiovascular imaging
10.1093/ehjci/jez178 · 2019
Evaluation of left ventricular enlargement as a marker of early disease in familial dilated cardiomyopathy
10.1161/circgenetics.110.958918 · 2011
Natural history of dilated cardiomyopathy due to lamin A/C gene mutations
10.1016/s0735-1097(02)02954-6 · 2003
Role of cardiac magnetic resonance in the diagnosis and prognosis of nonischemic cardiomyopathy
10.1016/j.jcmg.2017.08.005 · 2017
Assessment of myocardial deformation with cardiac magnetic resonance strain imaging improves risk stratification in patients with dilated cardiomyopathy
10.1093/ehjci/jeu181 · 2015
Myocardial tagging by cardiovascular magnetic resonance: evolution of techniques-pulse sequences, analysis algorithms, and applications
10.1186/1532-429x-13-36 · 2011
2022 AHA/ACC/HFSA guideline for the management of heart failure: a report of the American college of cardiology/American heart association joint committee on clinical practice guidelines
2022
Excessive trabeculation of the left ventricle: JACC: cardiovascular imaging expert panel paper
10.1016/j.jcmg.2022.12.026 · 2023
Prevalence and prognostic significance of left ventricular noncompaction in patients referred for cardiac magnetic resonance imaging
10.1161/circimaging.117.006174 · 2017
The prevalence and prognostic significance of right ventricular systolic dysfunction in nonischemic dilated cardiomyopathy
10.1161/circulationaha.113.002518 · 2013
Interstudy reproducibility of right ventricular volumes, function, and mass with cardiovascular magnetic resonance
2004
Right ventricular systolic dysfunction assessed by cardiac magnetic resonance is a strong predictor of cardiovascular death after coronary bypass grafting
10.1016/j.athoracsur.2015.11.035 · 2016
The prognostic value of late gadolinium-enhanced cardiac magnetic resonance imaging in nonischemic dilated cardiomyopathy: a review and meta-analysis
10.1016/j.jcmg.2018.03.006 · 2018
Left atrial evaluation by cardiovascular magnetic resonance: sensitive and unique biomarkers
10.1093/ehjci/jeab221 · 2021
10.1093/ehjci/jeaf014
10.1093/ehjci/jeaf014 · 2025
Left atrial strain impairment precedes geometric remodeling as a marker of post-myocardial infarction diastolic dysfunction
10.1016/j.jcmg.2020.05.041 · 2020
Clinical utility and prognostic value of left atrial volume assessment by cardiovascular magnetic resonance in non-ischaemic dilated cardiomyopathy
10.1093/eurjhf/hft019 · 2013
Myocardial fibrosis assessment using T1 and ECV mapping with histologic validation in chronic dilated cardiomyopathy
10.1016/j.jcmg.2022.05.002 · 2022
Prognostic value of right atrial strain derived from cardiovascular magnetic resonance in non-ischemic dilated cardiomyopathy
10.1186/s12968-022-00894-w · 2022
Independent prognostic value of functional mitral regurgitation in patients with heart failure. A quantitative analysis of 1256 patients with ischaemic and non-ischaemic dilated cardiomyopathy
10.1136/hrt.2011.225789 · 2011
Discordance between echocardiography and MRI in the assessment of mitral regurgitation severity: a prospective multicenter trial
10.1016/j.jacc.2014.12.047 · 2015
Outcomes and predictors of patients with moderate or severe functional mitral regurgitation and nonischemic dilated cardiomyopathy
10.1002/clc.24067 · 2023
The cellular basis of dilated cardiomyopathy in humans
10.1016/s0022-2828(08)80028-4 · 1995
Dilated cardiomyopathy is associated with an increase in the type I/type III collagen ratio: a quantitative assessment
10.1016/0735-1097(94)00557-7 · 1995
Diffuse myocardial fibrosis: mechanisms, diagnosis and therapeutic approaches
10.1038/s41569-020-00504-1 · 2021
Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance
10.1161/01.cir.0000078641.19365.4c · 2003
Left ventricular geometric remodeling in relation to non-ischemic scar pattern on cardiac magnetic resonance imaging
10.1007/s10554-014-0487-8 · 2014
Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies
10.1093/eurheartj/ehi258 · 2005
Nonischemic or dual cardiomyopathy in patients with coronary artery disease
10.1161/circulationaha.123.067032 · 2024
Cardiovascular magnetic resonance imaging phenotypes and long-term outcomes in patients with suspected cardiac sarcoidosis
10.1001/jamacardio.2022.2981 · 2022
Complementary value of cardiac magnetic resonance imaging and positron emission tomography/computed tomography in the assessment of cardiac sarcoidosis
10.1161/circimaging.117.007030 · 2018
Possible causes and clinical relevance of a “ring-like” late gadolinium enhancement pattern
10.1016/j.jcmg.2023.08.004 · 2024
Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy
10.1001/jama.2013.1363 · 2013
Electrophysiology studies in patients with dilated cardiomyopathies
10.1023/a:1021109130276 · 2002
Free breathing three-dimensional cardiac quantitative susceptibility mapping for differential cardiac chamber blood oxygenation—initial validation in patients with cardiovascular disease inclusive of direct comparison to invasive catheterization
10.1186/s12968-019-0579-7 · doi-reference
Assessment of myocardial microstructural dynamics by in vivo diffusion tensor cardiac magnetic resonance
10.1016/j.jacc.2016.11.051 · doi-reference
Diffusion tensor cardiovascular magnetic resonance imaging: a clinical perspective
10.1016/j.jcmg.2019.07.016 · doi-reference
Risk stratification in nonischemic dilated cardiomyopathy using CMR imaging: a systematic review and meta-analysis
10.1001/jama.2024.13946 · doi-reference
Extracellular volume is an independent predictor of arrhythmic burden in dilated cardiomyopathy
10.1038/s41598-021-03452-z · doi-reference
A novel cardiac magnetic resonance-based personalized risk stratification model in dilated cardiomyopathy: a prospective study
10.1007/s00330-023-10415-7 · doi-reference
Native T1 mapping and extracellular volume mapping for the assessment of diffuse myocardial fibrosis in dilated cardiomyopathy
10.1016/j.jcmg.2017.04.006 · doi-reference
T1 mapping in dilated cardiomyopathy with cardiac magnetic resonance: quantification of diffuse myocardial fibrosis and comparison with endomyocardial biopsy
10.1093/ehjci/jeu183 · doi-reference
Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans
10.1161/circulationaha.109.930636 · doi-reference
Lipomatous metaplasia is associated with ventricular tachycardia recurrence following ablation in patients with nonischemic cardiomyopathy
10.1016/j.jacep.2024.02.024 · doi-reference
Lipomatous metaplasia enables ventricular tachycardia by reducing current loss within the protected corridor
10.1016/j.jacep.2022.07.005 · doi-reference
Cardiac magnetic resonance–derived myocardial scar is associated with echocardiographic response and clinical prognosis of left bundle branch area pacing for cardiac resynchronization therapy
10.1093/europace/euad326 · doi-reference
Left bundle branch area pacing versus biventricular pacing as initial strategy for cardiac resynchronization
10.1016/j.jacep.2023.04.015 · doi-reference
Randomized trial of left bundle branch vs biventricular pacing for cardiac resynchronization therapy
10.1016/j.jacc.2022.07.019 · doi-reference
Cardiac MRI-derived myocardial fibrosis and ventricular dyssynchrony predict response to cardiac resynchronization therapy in patients with nonischemic dilated cardiomyopathy
10.1148/ryct.220127 · doi-reference
Impact of mechanical activation, scar, and electrical timing on cardiac resynchronization therapy response and clinical outcomes
10.1016/j.jacc.2014.02.533 · doi-reference
Delayed enhancement magnetic resonance imaging predicts response to cardiac resynchronization therapy in patients with intraventricular dyssynchrony
10.1016/j.jacc.2006.07.046 · doi-reference
Effect of posterolateral scar tissue on clinical and echocardiographic improvement after cardiac resynchronization therapy
10.1161/circulationaha.105.543678 · doi-reference
The problem of non-response to cardiac resynchronization therapy
10.1097/01.hco.0000198983.93755.99 · doi-reference
Gadolinium cardiovascular magnetic resonance predicts reversible myocardial dysfunction and remodeling in patients with heart failure undergoing beta-blocker therapy
10.1161/01.cir.0000095029.57483.60 · doi-reference
Effects of myocardial fibrosis and ventricular dyssynchrony on response to therapy in new-presentation idiopathic dilated cardiomyopathy: insights from cardiovascular magnetic resonance and echocardiography
10.1093/eurheartj/ehr391 · doi-reference
10.1016/j.ahj.2023.09.008
10.1016/j.ahj.2023.09.008 · doi-reference
Cardiovascular magnetic resonance-GUIDEd management of mild to moderate left ventricular systolic dysfunction (CMR GUIDE): Study protocol for a randomized controlled trial
10.1111/anec.12420 · doi-reference
Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy
10.1056/nejmoa033088 · doi-reference
Mechanisms underlying spontaneous and induced ventricular arrhythmias in patients with idiopathic dilated cardiomyopathy
10.1161/01.cir.98.22.2404 · doi-reference